A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 21, Issue SUPPL. 3, 1998, Pages

  Cornelissen, J J ^a   Fibbe, W E ^b   Schattenberg, A V M B ^c   Petersen, E J ^d   Willemze, R ^b   De Witte, Th J M ^c   Lowenberg B ^a   Verdonck, L F ^d   Biezen, A Vd ^e   Brand, R ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Blood stem cells; Disease; Graft versus host; Recovery; Relapse

Indexed keywords

ALEMTUZUMAB; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BLOOD DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; ROSETTE FORMATION; T LYMPHOCYTE; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; NETHERLANDS; RECURRENCE; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0031874443     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Demuynck H, Delforge M. Zachée P et al. An update on peripheral blood progenitor cell transplantation. Ann Hematol 1995; 71: 29-33.
2. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
3. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1669.
4. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2845.
5. Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15: 111-115.
6. Link H, Arseniev L, Bähre O et al. Transplantation of allogeneic CD34+ blood cells. Blood 1996; 87: 4903-4906.
7. Finke J, Brugger W, Bertz H et al. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors. Bone Marrow Transplant 1996; 18: 1081-1086.
8. Urbano-Ispizua A, Solano C, Brunet S et al for the allo-PBPCT Spanish group. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 1996; 18: 35-40.
9. Schmitz N, Bacigalupo A, Labopin M et al on behalf of the European Group for Blood and Marrow Transplantation (EBMT). Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 1996; 95: 715-723.
10. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow grafts. Blood 1995; 85: 1659-1665.
11. Poynton CH. T cell depletion in bone marrow transplantation. Bone Marrow Transplant 1988; 3: 265-269.
12. Marmont A, Horowitz MM, Gale RP et al. T cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2124.
13. Van Bekkum D. Graft-versus-host disease. In: Van Bekkum DW, Löwenberg B (eds). Bone Marrow Transplantation. Biological Mechanisms and Clinical Practice. Dekker: New York, 1985, pp 147-153.
14. Löwenberg B, Wagemaker G, Van Bekkum DW et al. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T lymphocyte-depleted bone marrow from HLA-identical donors. Bone Marrow Transplant 1986; 1: 133-137.
15. Verdonck LF, De Gast GC, Van Heugten HG, Dekker A. A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood 1990; 75: 776-780.
16. Verdonck LF, Dekker AW, De Gast GC et al. Allogeneic bone marrow transplantation with fixed low number of T cells in the marrow graft. Blood 1994; 83: 3090-3093.
17. Schattenberg A, De Witte Th, Preijers R et al. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. Blood 1990; 75: 1356-1359.
18. Willemze R, Richel DJ, Falkenburg JHF et al. In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation. Bone Marrow Transplant 1992; 9: 255-261.
19. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplants for hematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 1996; 17: 703-708.
20. Körbling M, Mirza N, Przepiorka D et al. Clinical outcome in 112 patients following HLA-identical allogeneic peripheral blood stem cell (PBSC) transplantation. Blood 1997; 90 (Suppl. 1): 224 (Abstr. 989).
21. Brown RA, Adkins D, DiPersio J, Goodnough T. Allogeneic peripheral blood stem cell transplantation (PBSC) is associated with an increased risk of chronic graft-versus-host disease. Blood 1997; 90 (Suppl. 1): 225 (Abstr. 991).
22. Clark A, Cook G, Chopra R et al. Allogeneic sibling PBSC transplantation results in improved engraftment kinetics but is associated with a high incidence of chronic GVHD. Blood 1997; 90 (Suppl. 1): 376 (Abstr. 1672).
23. Majolino P, Saglio G, Schime R et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996; 17: 555-560.
24. Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994; 84: 941-945.
25. Dreger P, Glass B, Uharek L, Schmitz N. Allogeneic peripheral blood progenitor cells: current status and future directions. J Hematother 1996; 5: 331-337.
26. Ringden O, Labopin M, Gluckman E et al. Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Transplant Proc 1997; 29: 733-734.